NEWS

2008, April 23th

New technologies available

Semi-synthesis technologies
D-(-)-a-p-hydroxyphenylglycine (chemical plus enzymatic)
D-aminoacids (alanine, serine, phenylalanine, p-Cl-phenylalanine)

Antibiotics
Spiramycin
Virginiamycin

2008, April 15th

Biofin Laboratories will attend

CPhI China
Pudong-Shanghai, 24th-26th June, 2008

CPhI South America
Rio De Janeiro, 19th-21st August, 2008

SITEMAP

  • HOME

    Biofin Laboratories brings a technical and managerial experience in industrial fermentation technology and biotechnology.

  • HISTORY

    Industrial fermentation technology for bulk production of APIs, antibiotic, anticancer, aminoacid, vitamin and bioproducts in general, is our background.

  • SERVICES

    Technology transfer is our work in the last twenty years with the international world of the biotechnology.

  • TECHNOLOGIES PORTFOLIO

    Technologies producing antibiotic, anticancer, Active Pharmaceutical Ingredients (APIs) and bio-products in general.

  • PARTNERSHIP

    Practical experience in the scale up of bulk production technologies.

  • ORGANIZATION

    Flexible, custom oriented and leader with industrial background.

  • GALLERY

    Our industrial bioprocesses are practically tested in our plant. Microbiology laboratories, Fermenter pilot plant, Down-stream phase plant, Semisynthesis laboratory, Analysis laboratory, Engineering.

  • CONTACT

    Biofin Laboratories has long experience in international cooperation for the industrial biotechnology.